Overview

Analysis of XTR006 PET Imaging in Non-cognitively Impaired Subjects, MCI Due toAD, and Mild to Moderate AD Subjects

Status:
Completed
Trial end date:
2024-01-10
Target enrollment:
Participant gender:
Summary
This is an investigator-initiated clinical (IIT)study.The main purpose of this study was to evaluate the diagnostic efficacy of XTR006 PET qualitative reading and quantitative analysis in detecting mild cognitive impairment(MCI)due to AD and mild to moderate AD based on clinical diagnosis, and to establish XTR006 PET imaging parameters and qualitative reading and quantitative analysis methods.
Phase:
N/A
Details
Lead Sponsor:
Sinotau Pharmaceutical Group